Commercial Readiness for Clinical-Stage Companies: Policy & Market Crosscurrents Redefining Biopharma Launch Success Webinar
Commercial Readiness for Clinical-Stage Companies: Policy & Market Crosscurrents Redefining Biopharma Launch Success Webinar
- Thursday, June 4, 2026
- 1:00 PM EST
In today’s environment, biopharma commercial strategy, launch success, and product net revenue performance are increasingly shaped by forces beyond the four walls of the organization. Policy volatility, pricing reform, IRA implementation, 340B expansion, state-level legislation, channel complexity, and evolving PBM and payer dynamics are converging to create unprecedented margin pressure.
Join IntegriChain Consulting Partner, Bruce Phelan, and Advisory Services Managing Director, Walt Worsham, for this complimentary webinar focused on commercial insights for biopharma, where they will provide the must-have elements of a successful biopharma commercial launch plan and translate today’s policy complexity into market access strategies.
- Policy updates – MFN, GENEROUS, GLOBE, GUARD, 340B
- Key elements of a successful new product launch plan by archetype
- Channel and contracting considerations to ensure patient access and efficiently convert demand
- How market structure shifts are altering access economics
- Operational considerations for gross-to-net forecasting and accruals